Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening | Zendy

J. A. Land | Zendy; Jan van Bergen | Zendy; Servaas A. Morré | Zendy; Maarten J. Postma | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening

Author(s) -

J. A. Land,

Jan van Bergen,

Servaas A. Morré,

Maarten J. Postma

Publication year - 2009

Publication title -

human reproduction update

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.977

H-Index - 180

eISSN - 1362-4946

pISSN - 1355-4786

DOI - 10.1093/humupd/dmp035

Subject(s) - pelvic inflammatory disease , chlamydia trachomatis , chlamydia , infertility , tubal factor infertility , cervicitis , medicine , gynecology , asymptomatic , population , epidemiology , obstetrics , immunology , biology , pregnancy , environmental health , genetics

The majority of Chlamydia trachomatis infections in women are asymptomatic, but may give rise to pelvic inflammatory disease (PID) and tubal infertility. Screening programmes aim at reducing morbidity in individuals by early detection and treatment, and at decreasing the overall prevalence of infection in the population. A number of modelling studies have tried to calculate the threshold prevalence of chlamydia lower genital tract infection above which screening becomes cost-effective. There is considerable debate over the exact complication rates after chlamydia infections, and more precise estimates of PID and tubal infertility are needed, for instance to be inserted in economic models.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research